Gilead price for a treatment of COVID-19 drug remdesivir: US$2340 to $3120

Author: Eamonn Sheridan | Category: News

Gilead Sciences is the maker of the treatment drug which is said to hasten recovery for severely ill coronavirus patients

  • it will charge US$2340 for a typical treatment course for people covered by government health programs in the US
  • price would be US$3120 for patients with private insurance

For bank trade ideas, check out eFX Plus
By continuing to browse our site you agree to our use of cookies, revised Privacy Notice and Terms of Service. More information about cookiesClose